HIGH-DOSE-RATE AND LOW-DOSE-RATE BRACHYTHERAPY AS MONOTHERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER. (2019). Voprosy Onkologii, 65(3), 434-440. https://doi.org/10.37469/0507-3758-2019-65-3-434-440